首页> 外文期刊>BMC Surgery >Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis
【24h】

Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing gastrectomy for gastric cancer: a systematic review and meta-analysis

机译:胃癌胃切除术患者控制营养状况(CONUT)评分的预后意义:系统评价和荟萃分析

获取原文
           

摘要

In recent years, the clinical evidence of the controlling nutritional status (CONUT) score has increased in patients with gastrointestinal cancers. The purpose of this systematic review and meta-analysis was to investigate the association between the preoperative CONUT score and outcomes in patients undergoing gastrectomy for gastric cancer (GC). A systematic literature search for studies reporting the prognostic impact of the CONUT score in patients with GC was conducted. Meta-analyses of survival, postoperative outcomes, and postoperative clinico-pathological parameters were conducted. Five studies with 2482 patients were found to be eligible and subsequently reviewed and analyzed. The CONUT score was significantly associated with overall survival (HR 1.85, 95%CI 1.38–2.48, P? 0.001), cancer-specific survival (HR 2.56, 95%CI 1.24–5.28, P?=?0.01) and recurrence/relapse-free survival (HR 1.43, 95%CI 1.12–1.82, P?=?0.004). Moreover, the CONUT score was associated with the incidence of postoperative complications (OR 1.39, P?=?0.003) and mortality (OR 6.97, P?=?0.04), and clinico-pathological parameters (T factor [OR 1.75, P? 0.001], N factor [OR 1.51, P? 0.001], TNM stage [OR 1.73, P? 0.001], and microvascular invasion [OR 1.50, P?=?0.006]), but not with tumor differentiation (OR 0.85, P?=?0.13). The preoperative CONUT score is an independent prognostic indicator of survival and postoperative complications, and is associated with clinico-pathological parameters in patients with GC.
机译:近年来,胃肠道癌症患者控制营养状况(CONUT)评分的临床证据有所增加。该系统评价和荟萃分析的目的是研究胃癌胃切除术(GC)患者术前CONUT评分与预后之间的关系。进行了系统的文献检索,研究报告了CONUT评分对GC患者的预后影响。进行了生存,术后结局和术后临床病理参数的荟萃分析。发现有5项针对2482例患者的研究符合条件,随后进行了回顾和分析。 CONUT评分与总体生存率(HR 1.85,95%CI 1.38–2.48,P <0.001),癌症特异性生存率(HR 2.56,95%CI 1.24–5.28,P <= 0.01)显着相关。无复发生存率(HR 1.43,95%CI 1.12–1.82,P <= 0.004)。而且,CONUT评分与术后并发症发生率(OR 1.39,P <= 0.003)和死亡率(OR 6.97,P <= 0.04)以及临床病理参数(T因子[OR 1.75,P?]有关。 <0.001],N因子[OR 1.51,P 0.001],TNM分期[OR 1.73,P 0.001]和微血管浸润[OR 1.50,P <= 0.006]),但不伴有肿瘤分化(OR 0.85,P≥0.13)。术前CONUT评分是生存和术后并发症的独立预后指标,并且与GC患者的临床病理参数有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号